ELYM Insider Trading Activity and SEC Form 4 Filings
ELYM insider trading summary
No open-market insider purchases or sales of Eliem Therapeutics, Inc. (ELYM) have been reported on SEC Form 4 in the past 12 months.
Latest ELYM insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 20, 2024 | Emily Pimblett | Chief Accounting Officer | Sell | $73 (9 @ $8.06) |
| Sep 20, 2024 | Emily Pimblett | Chief Accounting Officer | Sell | $10K (1,182 @ $8.18) |
| Jul 22, 2024 | Valerie Morisset | EVP, R&D and CSO | Sell | $315K (39,005 @ $8.07) |
| Jul 22, 2024 | Valerie Morisset | EVP, R&D and CSO | Sell | $239K (30,000 @ $7.98) |
| Jul 19, 2024 | Valerie Morisset | EVP, R&D and CSO | Sell | $362K (50,000 @ $7.24) |
| Jul 19, 2024 | Valerie Morisset | EVP, R&D and CSO | Sell | $72K (10,201 @ $7.09) |
| Jul 18, 2024 | Valerie Morisset | EVP, R&D and CSO | Sell | $267K (38,576 @ $6.93) |
| Jul 17, 2024 | Valerie Morisset | EVP, R&D and CSO | Sell | $22K (3,207 @ $6.91) |
| Jul 16, 2024 | Valerie Morisset | EVP, R&D and CSO | Sell | $357K (50,000 @ $7.13) |
| Jul 15, 2024 | Valerie Morisset | EVP, R&D and CSO | Sell | $297K (42,377 @ $7.01) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.